Response Biomedical appoints Chinese distributor:
This article was originally published in Clinica
Shanghai Kehua is to sell Canadian company Response Biomedical's RAMP cardiac marker tests for CK-MB, troponin I and myoglobin in China. Shanghai, the largest diagnostic reagent manufacturer and distributor in China, will also participate in the registration process. Response's RAMP system delivers highly accurate results in less than ten minutes, the company says. The total in vitro diagnostics market in China was estimated at $327 million in 1999 and this is expected to grow at a compound rate of 16.3% annually through 2005, according to Vancouver-based Response.